Back to Capital International Investors Capital International Investors

ABTABT
Showing 8 of 31 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in ABBOTT LABORATORIES

Capital International Investors holds 34.7M shares of ABT (ABBOTT LABORATORIES), worth $3.1B as of 2026-Q2. The position was decreased (-7.6% shares). ABT represents 0.7% of Capital International Investors's portfolio.

Current Value

$3.1B

Current Shares

34.7M

Total Value Change

-$4.3B

Total Shares Change

-31.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
34.7M
-7.6%
$3.1B0.7%$90.10
0
2026-Q1
Decreased
37.5M
-40.7%
$3.8B0.9%$101.31
0
2025-Q4
Increased
63.2M
+2.6%
$7.9B1.2%$123.00
52
2025-Q3
Increased
61.6M
+2.5%
$8.3B1.3%$130.91
51
2025-Q2
Decreased
60.1M
-10.0%
$8.2B1.4%$132.34
0
2025-Q1
Decreased
66.8M
-1.7%
$8.9B1.7%$128.48
0
2024-Q4
Increased
68M
+3.4%
$7.7B1.4%$108.98
52
2024-Q3
Decreased
65.7M
-8.4%
$7.5B1.4%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used